Our results provide support for high effectiveness of BNT162b2 against hospital admissions up until around 6 months after being fully vaccinated, even in the face of widespread dissemination of the ...

You’ve seen Jaylon kind of work on that behind the scenes as well, but he needs to quicken his jump shot. It’s still a little bit too slow for NBA standards.” More Cavs coverage ...

Tyrese Haliburton did it again. The Pacers trailed the Thunder by as much as 15 in Game 1 of the NBA Finals, but Indiana completed an epic comeback.

Recipients of the Pfizer mRNA vaccine experienced more all-cause deaths within the first 100 days post-vaccination than those who received the Moderna shot, a new study of 1.47 million people found..

Boston Consulting Group CEO apologizes for Israeli-backed Gaza aid project. Top consulting firm fires two partners over involvement in aid initiative beset by violence and controversy.

At the time of this writing, Pfizer had 108 candidates in its pipeline. Forty-seven were in the early phase 1 stage, 28 in phase 2, and 30 in late-stage development, phase 3.

Pfizer appears to be a very promising stock to buy if you're looking for income. That 7.3% dividend yield is terrific, and even if it gets slashed, it will likely still be substantial.

NPR speaks with a British orthopedic surgeon who just returned from his fourth medical mission to Gaza. He says many people he operated on were civilians and were shot while trying to reach food aid.

It initially looked as though it was also a game-winning shot, but Haliburton's foot was on the 3-point line. The Pacers won the game in overtime. They trailed by as many as 17 points in the game ...

The Indiana Pacers pulled off a stunning comeback in their NBA Finals opener, erasing a 15-point deficit to beat the Thunder 111-110 thanks to Tyrese Haliburton's game-winner.

Mike Breen’s call of Tyrese Haliburton’s game-winning shot with 0.3 seconds remaining in regulation on ABC was excellent, as usual. The voice of the NBA gave viewers the perfect mix of details ...